Increasing Breast Cancer Screening in Chinese Immigrants
2 other identifiers
interventional
99
1 country
1
Brief Summary
The long-term goal of this research is to increase breast cancer screening rates in NYC Chinese immigrants. The researchers plan to accomplish this objective by developing and testing a culturally- and linguistically-adapted Witness Project program for Chinese immigrants. To inform the intervention development, the study team will identify barriers and facilitators to breast cancer screening in Chinese immigrants through individual qualitative interviews. A total of 156 participants will be recruited during the entire study. In Aim 1 which started in July 2021, 60 women were recruited for in-depth interviews to assess their breast cancer knowledge, perceived barriers and benefits/risks to completing mammography, perceived susceptibility to breast cancer, fatalism, screening intention, acculturation, language preference, and health literacy. In Aim 2, 96 women will be recruited to participate in the pilot testing of the intervention. Recruitment will take place at community sites that serve Chinese immigrants in New York City. Enrollment for Aim 2 is anticipated to start in March of 2022.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jul 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2021
CompletedFirst Submitted
Initial submission to the registry
October 15, 2021
CompletedFirst Posted
Study publicly available on registry
October 22, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 13, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 13, 2022
CompletedResults Posted
Study results publicly available
June 10, 2024
CompletedJune 10, 2024
June 1, 2024
1.5 years
October 15, 2021
May 8, 2024
June 6, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Number of Participants That Scored Above 80% in the Feasibility and Acceptability Questionnaire
Post-program survey to access acceptability of adapted narrative education program. Full-scale from 0% to 100%, with a higher percent indicating greater acceptability. An arbitrary cutoff value of 80% acceptance will determine the interventions' acceptability for the study.
immediately post presentation (presentation approximately 1 hour)
Number of Participants Who Were Engaged in Program
Percent of participants who showed up to the Chinese-community-based organizations and would like to participate in the program to assess engagement rate of participants
Baseline
Percentage of Community Organizations Willing to Host Program
Percentage of Chinese Community-based organizations who were willing to host the program to assess feasibility. Engagement rate of Chinese-community-based organizations was used to access feasibility
7 months
Secondary Outcomes (1)
Change in Breast Cancer Knowledge
baseline and 6 months post intervention
Study Arms (1)
Chinese Immigrants
EXPERIMENTALNYC Chinese immigrants provided with narrative breast health education
Interventions
Health education program utilizing narrative messages to promote breast cancer screening in Chinese immigrant women will be delivered in a group format in the community
Eligibility Criteria
You may qualify if:
- ≥ 40 years of age
- female
- born in China
- read and speak Cantonese, Mandarin, or English
You may not qualify if:
- \- none
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Icahn School of Medicine at Mount Sinai
New York, New York, 10029, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Limitations and Caveats
The study utilized a convenience sample recruited from Chinese community-based organizations located in New York City, which may have contributed to the high percentage of insurance involvement (100%), primary care physician access (100%), and participants living in the United States for more than 20 years. Thus, the generalizability of the findings may be limited, particularly for populations with inadequate insurance coverage.
Results Point of Contact
- Title
- Lina Jandorf
- Organization
- Icahn School of Medicine at Mount Sinai
Study Officials
- PRINCIPAL INVESTIGATOR
Lina Jandorf
Icahn School of Medicine at Mount Sinai
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SCREENING
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor, Director
Study Record Dates
First Submitted
October 15, 2021
First Posted
October 22, 2021
Study Start
July 1, 2021
Primary Completion
December 13, 2022
Study Completion
December 13, 2022
Last Updated
June 10, 2024
Results First Posted
June 10, 2024
Record last verified: 2024-06
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL
- Time Frame
- Beginning 9 months and ending 36 months following article publication.
- Access Criteria
- Investigators whose proposed use of the data has been approved by an independent review committee ('learned intermediary') identified for this purpose. For individual participant data meta-analysis. Proposals may be submitted up to 36 months following article publication. After 36 months the data will be available in our University's data warehouse but without investigator support other than deposited metadata.
Individual participant data that underlie the results reported in this article, after deidentification (text, tables, figures, and appendices).